Drugs Information:
Acamprosate
Basic Information
|
||
ID | DDInter10 | |
Drug Type | small molecule | |
Molecular Formula | C5H11NO4S | |
Molecular Weight | 181.210 | |
CAS Number | 77337-76-9 | |
Description | Alcohol use disorder is responsible for a large worldwide burden of morbidity, premature mortality, and economic consequences resulting from accidents, violence, incarceration, decreased productivity, and increased healthcare spending.[A229073] Acamprosate, also known by the brand name Campral, is a drug used for the maintenance of alcohol abstinence. It is a structural analogue of the neurotransmitter γ-aminobutyric acid (GABA).[L31758] Acamprosate is the first medication specifically formulated for the maintenance of alcohol abstinence in ethanol-dependent patients after alcohol detoxification[A997], unlike [naltrexone] and [disulfiram]. It was first approved by the FDA in 2004 and initially marketed by Forest Laboratories.[L31783] | |
ATC Classification | N07BB03 | |
IUPAC Name | 3-acetamidopropane-1-sulfonic acid | |
InChI | AFCGFAGUEYAMAO-UHFFFAOYSA-N | |
Canonical SMILES | CC(=O)NCCCS(O)(=O)=O | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC |
Interactions with
Acamprosate
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|